Decoding the data: a comment on the American Heart Association/American Stroke Association (AHA/ASA) 2023 Guideline for the Management of patients with Aneurysmal Subarachnoid Hemorrhage

Guideline summary The 2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage was recently released with endorsements from multiple societies, including the Society of NeuroInterventional Surgery.1 All who worked on this document should be congratulated for their work, as it provides many updates, and addresses new components of aneurysmal subarachnoid hemorrhage (aSAH) care. We encourage providers to thoroughly read the statement. While this Guideline statement is thorough, it is important to highlight opportunities for future research, and gaps in the literature, where rigorous adherence to evidentiary levels leaves providers without clear guidance. There are several new topics and recommendations included in the Guideline. These include new updates supporting the treatment of aSAH patients with advanced age, while recommending against treatment of those with irreversible neurological injury. The Guideline clarifies the use of lumbar puncture in assisting in diagnosis, while supporting the use of diagnostic...
Source: Journal of NeuroInterventional Surgery - Category: Neurosurgery Authors: Tags: Commentary Source Type: research